Navigation Links
Lilly and MacroGenics Announce Licensing and Collaboration Agreement
Date:10/18/2007

Lilly to Acquire Phase III Molecule Teplizumab for the Treatment of Type 1

Diabetes

Companies to Collaborate on the Development of Autoimmune Disease

Treatments

ROCKVILLE, Md., and INDIANAPOLIS, Oct. 18 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) and MacroGenics, Inc. today announced that the two companies have entered into a global strategic alliance to develop and commercialize teplizumab, a humanized anti-CD3 monoclonal antibody, as well as other potential next generation anti-CD3 molecules for use in the treatment of autoimmune diseases. As part of the deal, Lilly will acquire the exclusive rights to the molecule. Teplizumab is currently being studied in the PROTEGE trial, a global pivotal Phase II/III clinical trial for individuals with recent-onset type 1 diabetes. MacroGenics will continue to oversee the PROTEGE trial.

Under the terms of the agreement, MacroGenics will receive an initial payment of $41 million, as well as $3 million in other committed funds. MacroGenics may also receive up to $200 million in potential development milestones for the type 1 diabetes indication. If teplizumab is successfully commercialized, MacroGenics may receive up to $250 million in potential sales milestones and would receive escalating royalties on sales commensurate with the current stage of development of the product. In addition, MacroGenics would have the option to co-promote teplizumab for certain indications in the U.S. Lilly may make an equity investment in MacroGenics of up to $10 million in the company's next private financing round or initial public offering. Lilly may also decide to pursue several additional indic
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Animal insulin product to be discontinued by drug major Eli Lilly
2. Did Eli Lilly Turn Wily With Regard to Their Best-selling Schizophrenia Drug?
3. Eli Lilly Releases Digital Insulin Pen
4. OHSU Researchers Announce New Discovery
5. PM announces a new health care order for India
6. Partnership Between Diabetes India And Elsevier Announced
7. US Politicians Urge Movie Moghuls To Add Anti-Smoking Announcements
8. Ramdoss Announces Introduction of RCH-II
9. Britain Announces Third Transfusion Related Mad Cow Case
10. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
11. Tibet Announces the Dalai Lama’s Tour of South Americ
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)...alth-related Questions for Tonight,s,Presidential ...- WebMD, the leading source of,health information,...ial,candidates, proposed health care policies, loc...t the candidates, stance on health insurance, medi... public health issues., The in-depth coverage is ...
(Date:10/7/2008)...PRNewswire-USNewswire/ -- The Ohio Nurses,Associat...ced today its,final round of endorsed candidates f...o Senate:, SD 26 Karen Gillmor (R) Tiffin, Ohio ...(R) Grove City;, HD 28 Connie Pillich (D) Cincinn...These ONA-endorsed candidates for the Ohio General...
(Date:10/7/2008)...wswire-USNewswire/ -- Kristi Yamaguchi, Olympic,Go... the Stars, has been,named chairperson for the 200...gn in an effort to help raise funds in support of ...e and promote lung health., The American Lung Ass...o conquer Tuberculosis. Today, the Lung Associatio...
(Date:10/7/2008)...ar to more expensive whole-leg color ultrasound, ...lthDay News) -- An older, simpler test to look for...osis, or DVT -- is as effective as a newer, more e...searchers found that 2-point ultrasonography of th...trasound -- was as good at detecting DVT as the ne...
Breaking Medicine News(10 mins):Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3
...Susan Butcher the famous iditarod champion was det...rticipate in the 300-mile sled dog race conducted ...of the 1100-mile Iditarod Trail Sled Dog Race. She...ce of survival with the same grit and confidence. ...
...There appears to be a remarkable laxity among the ...ng skin cancer. Felipe Beltran, the spokesman for ... has admitted that the organization’s drive agains...ed impact. The online study of the QIMR did not e...
...Researchers from Germany have discovered a novel, ...of coronary veins. This technique, called ECG-gate...DCT, is associated with very few complications // ... improved diagnostic quality and treatment. A com...
...A research was conducted by Selda Samakoglu and co...nter. This research opened new doors in the treatm.... The treatment combines both gene therapy and RNA...eatment has worked well in the laboratory stage an...
Other Medicine News:Health News:Treatment of Sickle Cell Anemia Using Gene Therapy. 2
(Date:10/7/2008)... - Data Presented Today at ACG Annual Scientific...stCall/ -- Ironwood,Pharmaceuticals, Inc. (formerl...YSE: FRX ) today announced the presentation of re...s safety and efficacy in 420 patients with,irritab...sis of the data,indicates that once- daily oral do...
(Date:10/7/2008)...RKELEY, Calif., Oct. 7 /- Aerovance I... data from a Phase I trial of its Aerovant,inhalat... no evidence of,local irritancy following asthma p... 10 mg dose will be the highest of three doses inv...udy, which is scheduled to begin early,next year. ...
(Date:10/7/2008)...tient, Prospective Randomized Placebo-Controlled P...cant Improved Overall Survival., MOUNTAIN VIEW, C...apeutics has now evaluated the mature Phase II dat...didate PROSTVAC(TM) that had been,obtained as part...onal,Cancer Institute (NCI) in the US., The resul...
(Date:10/7/2008)...nned 15 Patient Cohort Enrolled in Stage A of Tria...on With Carboplatin and Paclitaxel -, TUSTIN, Cal...armaceuticals, Inc. (Nasdaq: PPHM ), a clinical s...al antibodies for the treatment of cancer and,hepa...t it has completed,enrollment in the first stage o...
Breaking Medicine Technology:Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 3Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 4CorVel Announces Appearance at Bank of America Health Care Conference 18732 1CorVel Announces Appearance at Bank of America Health Care Conference 18732 2San Diego State University Controlled Substance Investigation 18730 1Workers With No Healthcare Protecting Kaiser Facilities Security Contractor May Be Misleading Californias Largest Healthcare Provider 18728 1Workers With No Healthcare Protecting Kaiser Facilities Security Contractor May Be Misleading Californias Largest Healthcare Provider 18728 2Physical Therapist Stresses Funding for Falls Prevention at National Safety Council Briefing 18726 1Physical Therapist Stresses Funding for Falls Prevention at National Safety Council Briefing 18726 2
... Mass.--(BUSINESS WIRE)--Apr 18, 2007 - Gloucester...rmaceutical,company, announced today that encourag...mbination of romidepsin and erlotinib in,non-small...human,cancer patients were presented at the Americ...eeting taking place in Los Angles,CA. The study w...
...ies Confirm That Fusion Proteins Made by Combining...onstrate Increased,Anti-Tumor Activity With No Obs..., April 18, 2007,/PRNewswire-FirstCall/ -- Peregri...rmaceutical company developing targeted,monoclonal...tis C,virus infection, today reported that data pr...
Other Medicine Technology:Gloucester Pharmaceuticals Reports on Romidepsin and Erlotinib,Combination in Non-Small Cell Lung Cancer Presented at American,Association of Cancer Research Annual Meeting 2Gloucester Pharmaceuticals Reports on Romidepsin and Erlotinib,Combination in Non-Small Cell Lung Cancer Presented at American,Association of Cancer Research Annual Meeting 3Data Presented at AACR Meeting Shows Peregrine's Immunocytokine,Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in,Preclinical Studies 2Data Presented at AACR Meeting Shows Peregrine's Immunocytokine,Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in,Preclinical Studies 3Data Presented at AACR Meeting Shows Peregrine's Immunocytokine,Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in,Preclinical Studies 4
...ing: The Procleix System has added a significant ... utilizes innovative technologies developed by Gen...eic acid amplification technique called Transcript...V-1/HCV Assay can simultaneously detect the presen...
EIA for Donor Screening. Synthetic peptide Enzyme Immunoassay (EIA) for the detection of antibodies to Human Immunodeficiency Virus Types 1 and/or 2,(HIV-1 and HIV-2) in human serum, plasma or ca
...assay: Uni-Gold Recombigen HIV is a single use rap...in plasma, serum and whole blood (venipuncture). U...t of care settings as an aid in diagnosis of infec...appropriate multi-test algorithms designed for the...
The advanced performance benefits of TiMAX material have been applied to the ACE Pe.R.I. (Periarticular Reduction Implants) Upper Extremity Plates. Greater strength, less rigidity combine to provide
Medicine Products: